Feasibility and Performance of Multiple Urinary HPV Detection Assays in Women with Known Cervical HPV Status: A Pilot Study
This pilot study demonstrates that while standard urine bottles failed to detect HPV, the Colli-Pee collection device combined with PCR testing achieved a 60% detection rate in HPV-positive women, suggesting that optimized non-invasive urine-based screening is a promising complementary approach to conventional cervical sampling.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Cervical cancer remains one of the most preventable yet persistent threats to women's health globally, particularly in regions where regular medical screening is difficult to access. The disease is almost always caused by a persistent infection with a virus called human papillomavirus, or HPV. In a typical screening process, a doctor collects cells directly from the cervix to check for the virus's genetic material. While this method is highly accurate, it requires a clinical visit and a physical exam that many women find uncomfortable or embarrassing, leading some to skip screening entirely. Scientists have long sought a simpler alternative: testing urine. Since the virus sheds cells from the cervix that can wash into the first part of the urine stream, a urine test could offer a private, painless way to detect the infection. However, the success of such a test depends entirely on how the urine is collected and how sensitive the laboratory tools are at finding tiny traces of the virus.
A team of researchers at the All India Institute of Medical Sciences in New Delhi set out to test whether urine could reliably replace the traditional cervical swab for finding HPV. They focused on two critical variables: the method used to catch the urine and the laboratory technique used to find the virus. The team recruited 30 women who had already been screened; 15 of these women were known to carry the virus in their cervix, while the other 15 were known to be free of it. To compare collection methods, each woman provided two samples of her first-void urine—the very first stream of the day. The first sample was collected in a standard, disposable plastic cup, the kind used in most clinics for routine tests. The second sample was collected using a specialized device called Colli-Pee, which is designed to capture only that initial stream and immediately mix it with a preservative to keep the genetic material stable.
The results revealed a stark difference between the two ways of gathering the sample. When the researchers analyzed the urine collected in the standard disposable cups, they found no trace of the virus in any of the samples, even from the women who were known to be infected. The virus was simply undetectable in these samples. In contrast, the urine collected with the specialized Colli-Pee device told a different story. Among the 15 women with confirmed cervical infections, the device allowed the researchers to find the virus in 9 of them using a highly sensitive molecular technique called polymerase chain reaction, or PCR. This method acts like a magnifying glass for genetic code, making tiny amounts of viral material visible. Another technique, known as a line probe assay, which can identify specific types of the virus, found the virus in 7 of the 15 infected women. The third method, a widely used test called Hybrid Capture-2, detected the virus in only 3 of the 15 women. Crucially, none of the 15 women who did not have the virus showed any sign of it in their urine, regardless of which collection method or laboratory test was used. This means the urine tests did not produce any false alarms.
The study also looked at the women's cervical health through a procedure called colposcopy, which allows doctors to view the cervix with a magnifying instrument. Most of the women had normal results, but two had early signs of cell changes that could lead to cancer. When the researchers looked at the urine samples from these two women, the specialized Colli-Pee collection combined with the laboratory tests successfully identified the virus in both cases. The standard cup collection, however, failed to detect the virus in either of them. Beyond just finding the virus, the researchers compared how the women felt about the two sampling methods. Every single participant found collecting urine easy or moderately easy, whereas only 80 percent felt the same way about the traditional cervical swab.
The researchers concluded that while urine testing holds great promise as a non-invasive alternative, the way the sample is collected matters more than the laboratory test itself. The standard cup method was ineffective, likely because the virus was too diluted or degraded by the time it was tested. The specialized device, by capturing the right portion of the urine and protecting it, significantly improved the chances of finding the virus. However, the study also showed that even with the best device, urine testing did not find the virus in every single infected woman, meaning it is not yet a perfect replacement for the cervical swab. The findings suggest that if urine testing is to become a standard part of cancer screening, it must use specialized collection devices and highly sensitive laboratory methods. Until larger studies confirm these results, urine testing remains a promising, comfortable option that could help reach more women, but it requires careful handling to work correctly.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.